Stem cell transplant from a partially matched unrelated donor
Treatments studied
Part of Blood & lymphatic clinical trials.
This trial tests a transplant using stem cells from an unrelated donor who is not a perfect match for your tissue type. It may be an option for people with blood cancers who can't find a fully matched related donor and need a transplant quickly.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 60 years old
- You have a blood cancer (like leukemia or lymphoma) that needs a stem cell transplant
- A matched sibling or other close relative is not available for donation
- You do not have a fully matched (9 out of 10 or better) unrelated donor available, or your condition is urgent
- You have a willing donor who is a partial match (less than 9 out of 10 in tissue type)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a stem cell transplant from a family donor whose tissue type is only partly matched, for adults with blood cancers who don't have a fully matched sibling or other closely matched donor. The goal is to make transplant possible for more patients.
This trial tests a special type of stem cell transplant that may help people with certain blood cancers or bone marrow diseases. The transplant uses donor stem cells that are specially selected to reduce the risk of complications. It might be an option for patients who need a transplant to treat their condition.
This trial uses a stem cell transplant from a partially matched family member or unrelated donor to treat cancer and other blood disorders. Because the donor isn't fully matched, the transplant uses a special method to select certain stem cells (CD34-selected) to help reduce complications.
This trial offers a stem cell transplant using a half-matched family donor and/or cord blood for people with high-risk or hard-to-treat cancers or blood disorders. It aims to provide a treatment option when a perfectly matched donor is not available.
This trial studies transplanting healthy blood-forming cells from an umbilical cord blood donor who is not related to you. It may help people with certain blood cancers, immune disorders, or other serious diseases when a standard transplant plan is needed.
This trial tests a stem cell transplant using milder chemotherapy (treosulfan and fludarabine) followed by a drug called cyclophosphamide to prevent graft-versus-host disease. It aims to make transplant safer for people with blood diseases who cannot handle standard high-dose chemotherapy.
Hear when a new Hematologic Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.